Back to search

Cornell University

Affinity-tuning leukocyte integrin for development of safe therapeutics

Abstract

dc:description.abstract

Much attention has been given to the molecular and cellular pathways linking inflammation with cancer and the local tumor environment to identify new target molecules that could lead to improved diagnosis and treatment. Among the many molecular players involved in the complex response, central to the induction of inflammation is intercellular adhesion molecule (ICAM)-1, which is of particular interest for its highly sensitive and localized expression in response to inflammatory signals. ICAM-1, which has been implicated to play a critical role in tumor progression in various types of cancer, has also been linked to cancer metastases, where ICAM-1 facilitates the spread of metastatic cancer cells to secondary sites. This unique expression profile of ICAM-1 throughout solid tumor microenvironment makes ICAM-1 an intriguing molecular target, which holds great potential as an important diagnostic and therapeutic tool. Herein, we have engineered the ligand binding domain, or the inserted (I) domain of a leukocyte integrin, to exhibit a wide range of monovalent affinities to the natural ligand, ICAM-1. Using the resulting I domain variants, we have created drug and gene delivery nanoparticles, as well as targeted immunotherapeutics that have the ability to bind and migrate to inflammatory sites prevalent in tumors and the associated microenvironment. Through the delivery of diagnostic agents, chemotherapeutics, and immunotherapeutics, the following chapters demonstrate that the affinity enhancements achieved by directed evolution bring the affinity of I domains into the range optimal for numerous applications.

Degree

thesis:*
Name thesis:degree_name
Ph. D., Biomedical Engineering
Level thesis:degree_level
Doctor of Philosophy
Discipline thesis:degree_discipline
Biomedical Engineering
Grantor
Cornell University
Year dc:date.issued
2017

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Park, Spencer
Chair dc:contributor.chair
  • Jin, Moonsoo
Committee members dc:contributor.committeemember
  • Zarnegar, Rasa
  • King, Michael R.

Subjects

dc:subject × 8

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Dc Identifier Bibid
9906083
Dc Identifier Other
ProQuest Submission ID: 10003
ProQuest Publication ID: 10168348

Chain of custody

source
Harvested from
Cornell University
Base URL
ecommons.cornell.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Park, Spencer. Affinity-tuning leukocyte integrin for development of safe therapeutics. Doctor of Philosophy thesis, Cornell University, 2017. https://hdl.handle.net/1813/47836